AOP Orphan Pharmaceuticals Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 400
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 4

AOP Orphan Pharmaceuticals General Information

Description

Developer of treatments for rare diseases. The company is engaged in the research, development, production and distribution of drugs and niche generics in the areas of hematology and oncology, cardiology and pulmonology, neurology and psychiatry, and metabolic diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors (Healthcare)
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Wilhelminenstraße 91/IIf
  • Vienna, 1160
  • Austria
+43 01 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AOP Orphan Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AOP Orphan Pharmaceuticals‘s full profile, request access.

Request a free trial

AOP Orphan Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of treatments for rare diseases. The company is engaged in the research, development, production and distribut
Distributors (Healthcare)
Vienna, Austria
400 As of 2021
0000 0000-00-00
000000&0

000000 0

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000 000000000
Emeryville, CA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000

0000000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
00000 000000000000000 000 0000000000000
New York, NY
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AOP Orphan Pharmaceuticals Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adamas Pharmaceuticals Corporate Backed or Acquired Emeryville, CA 000 00000 000000&0 00000
0000000 00000000 Formerly VC-backed New York, NY 00 00000 00000000 00000
0000 0000000000000 Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
0000000 0000000000 Formerly VC-backed Needham, MA 00 00000 000000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

AOP Orphan Pharmaceuticals Patents

AOP Orphan Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210212985-A1 Cannabinoids for prophylactic treatment of involuntary weight loss Pending 24-Nov-2016 000000000
CA-3044880-A1 Cannabinoids for prophylactic treatment of involuntary weight loss Pending 24-Nov-2016 0000000000
US-20190388383-A1 Cannabinoids for prophylactic treatment of involuntary weight loss Granted 24-Nov-2016 0000000000
US-10940136-B2 Cannabinoids for prophylactic treatment of involuntary weight loss Active 24-Nov-2016 0000000000 0
EP-3544598-B1 Cannabinoids for prophylactic treatment of involuntary weight loss Active 24-Nov-2016 A61K31/352
To view AOP Orphan Pharmaceuticals’s complete patent history, request access »

AOP Orphan Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Andreas Steiner Chief Executive Officer & Board Member
Agnes Kohl Director, Business & Program Development
Bernhard Nachbaur Director, Finance
Gunther Krumpl Chief Corporate Development Officer & Board Member
Rudolf Widmann Founder, Chief Therapeutics Development Officer & Board Member
To view AOP Orphan Pharmaceuticals’s complete executive team members history, request access »

AOP Orphan Pharmaceuticals Board Members (4)

Name Representing Role Since
0000000 0000000 AOP Orphan Pharmaceuticals Chief Executive Officer & Board Member 000 0000
00000 0000000 AOP Orphan Pharmaceuticals Board Member 000 0000
0000000 000000 AOP Orphan Pharmaceuticals Chief Corporate Development Officer & Board Member 000 0000
000000 0000000 AOP Orphan Pharmaceuticals Founder, Chief Therapeutics Development Officer & Board Member 000 0000
To view AOP Orphan Pharmaceuticals’s complete board members history, request access »

AOP Orphan Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AOP Orphan Pharmaceuticals Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Sep-2020 0000000000 Pharmaceuticals
00000 000000 10-Aug-2011 00000 0000 00.000 Other Healthcare
000000 0000000000 Pharmaceuticals
Shield Therapeutics Early Stage VC 00.000 Pharmaceuticals
To view AOP Orphan Pharmaceuticals’s complete investments and acquisitions history, request access »

AOP Orphan Pharmaceuticals Subsidiaries (2)

Company Name Industry Location Founded
SciPharm Pharmaceuticals Luxembourg 2010
000000 Pharmaceuticals Vienna, Austria 0000
To view AOP Orphan Pharmaceuticals’s complete subsidiaries history, request access »

AOP Orphan Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000 10-Aug-2011 00000 00000 00 00.000 Completed
  • 2 buyers
Shield Therapeutics Early Stage VC 00.000 Completed
  • 2 buyers
To view AOP Orphan Pharmaceuticals’s complete exits history, request access »